Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Gastrointestinal Diseases and Overcoming Antibiotic Resistance with Gilead Raday Redhill Biopharma TRANSCRIPT
Download PDFJul 30, 2019
Gilead Raday, COO, Redhill Biopharma, a specialty biopharmaceutical company primarily focused on gastrointestinal (GI) diseases talks about the growing problem of antibiotic resistance and the challenges this presents treating H. pylori infections, which affects about half of the global population. Redhill is working...
Jul 30, 2019
Gilead Raday, COO, Redhill Biopharma, a specialty biopharmaceutical company primarily focused on gastrointestinal (GI) diseases talks about the growing problem of antibiotic resistance and the challenges this presents treating H. pylori infections, which affects about half of the global population. Redhill is working...
Decentralizing Research and Development of Molecular Compounds with Paul Kohlhaas Molecule TRANSCRIPT
Download PDFJul 22, 2019
Paul Kohlhaas, Founder, Molecule is passionate about creating a network for the decentralization of the process of researching new molecules and developing new molecular compounds using blockchain to track and reward all those who participate. With the current pharma innovation crisis and rising costs of drug...
Jul 22, 2019
Paul Kohlhaas, Founder, Molecule is passionate about creating a network for the decentralization of the process of researching new molecules and developing new molecular compounds using blockchain to track and reward all those who participate. With the current pharma innovation crisis and rising costs of drug...
Novel Treatment for Rare Neuroendocrine Diseases with Dr. Nerissa Kreher Tiburio TRANSCRIPT
Download PDFJul 16, 2019
Dr. Nerissa Kreher, Chief Medical Officer, Tiburio discusses the company's lead asset, TBR-760 as a novel treatment option for patients with non-functioning pituitary adenomas (NFPA), which are rare neuroendocrine tumors located in the pituitary gland. She also speaks about the challenges facing patients even...